SS Innovations International, Inc. (NASDAQ: SSII) has recently achieved a significant milestone in the field of surgical robotics. According to the press release dated September 16, 2025, the company successfully completed the world's first pediatric pyeloplasty telesurgery using its SSI Mantra Surgical Robotic System. This groundbreaking procedure was carried out by Dr. Chandra Mohan Vaddi, the Managing Director of Preeti Urology & Kidney Hospitals, who remotely performed the robotic surgery from SS Innovations' headquarters in Gurugram, India, on a 16-month-old patient located nearly 1,000 miles away at Preeti Hospital in Hyderabad, India.
The SSI Mantra Surgical Robotic System has demonstrated its capabilities in various telesurgeries across different categories, including pediatric, cardiac, urology, gynecology, oncology, and general surgery. To date, over 50 telesurgeries have been successfully conducted at distances of up to 4,000 miles using the SSI Mantra Surgical Robotic System.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, emphasized the potential benefits of robotic surgery over traditional methods, citing advantages such as increased precision, minimally invasive procedures with smaller incisions, reduced pain, and faster recovery times. This is particularly significant in pediatric surgery and general surgery, where these factors are crucial considerations.
The company's commitment to addressing the unmet needs in the pediatric surgical robotics market aligns with its mission of extending advanced surgical robotic care to underserved communities. SS Innovations aims to further enhance the SSI Mantra's capabilities in pediatric robotic surgery through the development of smaller instrumentation, aiming to make world-class care more accessible to a larger segment of the global population.
SS Innovations International, Inc. is known for developing innovative surgical robotic technologies, including its proprietary SSI Mantra Surgical Robotic System and the comprehensive suite of SSI Mudra Surgical Instruments. The company's vision is to make robotic surgery affordable and accessible to a larger segment of the global population. As the company continues to expand its global presence, it aims to offer technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
The successful completion of the world's first pediatric pyeloplasty telesurgery using the SSI Mantra Surgical Robotic System underscores SS Innovations' leadership in pioneering new telesurgeries across different procedure types and its dedication to democratizing advanced surgical robotic care for patients in need. Following these announcements, the company's shares moved -6.9%, and are now trading at a price of $5.40. If you want to know more, read the company's complete 8-K report here.
